Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Antiviral Chemistry & Chemotherapy
|
October 28, 2006
AZT and AZT-monophosphate prodrugs incorporating HIV-protease substrate fragment: synthesis and evaluation as specific drug delivery systems
Jean-François Liotard, Mohamed Mehiri, Audrey Di Giorgio, et al.
Journal of Medicinal Chemistry
|
November 30, 2004
New constrained "molecular tongs" designed to dissociate HIV-1 protease dimer
Naïma Merabet, Julien Dumond, Bruno Collinet, et al.
Biochemistry
|
December 25, 2008
Dimer disruption and monomer sequestration by alkyl tripeptides are successful strategies for inhibiting wild-type and multidrug-resistant mutated HIV-1 proteases
Ludovic Bannwarth, Thierry Rose, Laure Dufau, et al.
Journal of Medicinal Chemistry
|
November 19, 2009
Novel organic proteasome inhibitors identified by virtual and in vitro screening
Nicolas Basse, Matthieu Montes, Xavier Maréchal, et al.
Journal of Medicinal Chemistry
|
May 22, 2007
Linear TMC-95-based proteasome inhibitors
Nicolas Basse, Sandrine Piguel, David Papapostolou, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 19, 2014
New C(4)- and C(1)-derivatives of furo[3,4-c]pyridine-3-ones and related compounds: evidence for site-specific inhibition of the constitutive proteasome and its immunoisoform
Anna Hovhannisyan, The Hien Pham, Dominique Bouvier, et al.
Chemmedchem
|
August 18, 2010
20S proteasome inhibition: designing noncovalent linear peptide mimics of the natural product TMC-95A
Michael Groll, Nerea Gallastegui, Xavier Maréchal, et al.
Journal of Medicinal Chemistry
|
November 14, 2003
Dimerization inhibitors of HIV-1 protease based on a bicyclic guanidinium subunit
Perla Breccia, Nicole Boggetto, Ruth Pérez-Fernández, et al.
Biochemical and Biophysical Research Communications
|
January 23, 2018
Piperlongumine and some of its analogs inhibit selectively the human immunoproteasome over the constitutive proteasome
Elodie Bosc, Jhennifer Nastri, Valérie Lefort, et al.
Journal of Medicinal Chemistry
|
December 10, 2014
Toward the first class of suicide inhibitors of kallikreins involved in skin diseases
Xiao Tan, Feryel Soualmia, Laetitia Furio, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Antiviral Chemistry & Chemotherapy
|
October 28, 2006
AZT and AZT-monophosphate prodrugs incorporating HIV-protease substrate fragment: synthesis and evaluation as specific drug delivery systems
Jean-François Liotard, Mohamed Mehiri, Audrey Di Giorgio, et al.
Journal of Medicinal Chemistry
|
November 30, 2004
New constrained "molecular tongs" designed to dissociate HIV-1 protease dimer
Naïma Merabet, Julien Dumond, Bruno Collinet, et al.
Biochemistry
|
December 25, 2008
Dimer disruption and monomer sequestration by alkyl tripeptides are successful strategies for inhibiting wild-type and multidrug-resistant mutated HIV-1 proteases
Ludovic Bannwarth, Thierry Rose, Laure Dufau, et al.
Journal of Medicinal Chemistry
|
November 19, 2009
Novel organic proteasome inhibitors identified by virtual and in vitro screening
Nicolas Basse, Matthieu Montes, Xavier Maréchal, et al.
Journal of Medicinal Chemistry
|
May 22, 2007
Linear TMC-95-based proteasome inhibitors
Nicolas Basse, Sandrine Piguel, David Papapostolou, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 19, 2014
New C(4)- and C(1)-derivatives of furo[3,4-c]pyridine-3-ones and related compounds: evidence for site-specific inhibition of the constitutive proteasome and its immunoisoform
Anna Hovhannisyan, The Hien Pham, Dominique Bouvier, et al.
Chemmedchem
|
August 18, 2010
20S proteasome inhibition: designing noncovalent linear peptide mimics of the natural product TMC-95A
Michael Groll, Nerea Gallastegui, Xavier Maréchal, et al.
Journal of Medicinal Chemistry
|
November 14, 2003
Dimerization inhibitors of HIV-1 protease based on a bicyclic guanidinium subunit
Perla Breccia, Nicole Boggetto, Ruth Pérez-Fernández, et al.
Biochemical and Biophysical Research Communications
|
January 23, 2018
Piperlongumine and some of its analogs inhibit selectively the human immunoproteasome over the constitutive proteasome
Elodie Bosc, Jhennifer Nastri, Valérie Lefort, et al.
Journal of Medicinal Chemistry
|
December 10, 2014
Toward the first class of suicide inhibitors of kallikreins involved in skin diseases
Xiao Tan, Feryel Soualmia, Laetitia Furio, et al.
Page
of 5